TargaZyme
Company profile on P2PMarketData. TargaZyme is a biotechnology company based in Carlsbad, CA, founded in 2005. It has raised $73.9K through crowdfunding on StartEngine.
TargaZyme is a biotechnology company based in Carlsbad, California. The company focuses on developing cancer therapeutics that leverage a patient's immune system, aiming to provide alternatives to traditional cancer treatments. TargaZyme has two key products in development: TZ101, a Phase-3 ready product, and TZ102, which is being prepared for clinical trials.
Frequently asked questions about TargaZyme
How much funding has TargaZyme raised?
TargaZyme has raised $73.9K through crowdfunding across 1 round tracked by P2PMarketData, from 84 investors.
What is TargaZyme's valuation?
TargaZyme had an indicative valuation of $196M in its 2022 funding round.
Is TargaZyme profitable?
No. TargaZyme reported a net loss of $2.4M for fiscal year 2021.
How many employees does TargaZyme have?
TargaZyme reported 2 employees for fiscal year 2021.
When was TargaZyme founded?
TargaZyme was founded in November 2005.
Where is TargaZyme based?
TargaZyme is headquartered in Carlsbad, California, United States.
What industry is TargaZyme in?
TargaZyme operates in the Biotechnology industry within the Healthcare sector.